The FDA’s Division of Color Certification and Technology (DCCT) seeks a brand‑name‑or‑equal, bench‑top single quadrupole ICP‑MS system to replace an aging Agilent 7800. The instrument must be a turnkey solution with integrated software that controls all components (autosampler, dilution system, reaction cell, plasma, mass analyzer, etc.) and include on‑site installation, training, a three‑day consulting period, and a one‑year warranty with unlimited on‑site support. Key performance specifications include a compact footprint (< 35″ × 45″ × 35″), kinetic‑energy‑discrimination collision/reaction cell, hyperbolic quadrupole (2‑260 amu), mass scan speed > 3000 amu/sec, mass stability ≤ 0.05 u/day, dynamic range of ≥ 9 orders, and sensitivity ≥ 50 Mcps/ppm. The system must also provide advanced dilution, high‑throughput autosampling (≥ 42 vials), quiet roughing pump, heat‑exchanger/chiller, and a comprehensive spares kit. Optional three‑year service agreements are allowed but not mandatory.
• Replace Agilent 7800 ICP‑MS (support ends Oct 2028)
• Bench‑top design, footprint < 35″ × 45″ × 35″
• Single‑software control of all modules, Windows‑based
• Kinetic‑energy‑discrimination collision/reaction cell (up to 3 gas lines)
• Hyperbolic quadrupole, 2‑260 amu, > 3000 amu/sec scan speed
• Mass stability ≤ 0.05 u/day, dynamic range ≥ 9 decades
• Autosampler ≥ 42 vials, temperature‑controlled spray chamber, high‑matrix capability (≥ 5 % TDS)
• Included installation, 3‑day on‑site training, 1‑year warranty with unlimited support
• Optional 3‑year service agreement (parts & labor)